Skip to content

Clinical trials

Phase 2 Scleroderma, Systemic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 2 Country / region: Italy Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20091
20121
20132
20151
20162
20192
20223
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated5
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ISDIN2
Lakefront Biotherapeutics NV2
Sanofi2
Amgen1
Artiva Biotherapeutics, Inc.1
Azienda Ospedaliera Universitaria Policlinico1
Bayer1
Boehringer Ingelheim1
Celgene1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic17
Scleroderma, Diffuse4
Lung Diseases, Interstitial3
Arthritis, Rheumatoid1
Familial Primary Pulmonary Hypertension1
Fibrosis1
Hypertension, Pulmonary1
Myositis1
Sjogren's Syndrome1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.